Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2018 Summer;12(2):92-96.

Aripiprazole Lauroxil NanoCrystal ® Dispersion Technology (Aristada Initio ® )

Megan J Ehret, Erica Davis, Sarah E Luttrell, Caroline Clark
  • PMID: 30040476
Randomized Controlled Trial

Aripiprazole Lauroxil NanoCrystal ® Dispersion Technology (Aristada Initio ® )

Megan J Ehret et al. Clin Schizophr Relat Psychoses. 2018 Summer.

Abstract

Nonadherence to antipsychotic medications for the treatment of schizophrenia is a widely recognized concern, leading to poorer clinical outcomes and higher treatment costs. Long-acting injectable (LAI) antipsychotics offer an extended dosing interval option for patients, although the current options may require an oral overlap at initiation. Aripiprazole lauroxil is an LAI that offers multiple dosing options but requires oral treatment overlap during initiation for the first 21 consecutive days. As an alternative to oral overlap, a novel nano-crystalline milled dispersion delivery system of aripiprazole lauroxil was recently approved as a one-day regimen to be added to aripiprazole lauroxil treatment.

Keywords: Antipsychotic; Aripiprazole; Schizophrenia.

PubMed Disclaimer

Publication types

MeSH terms